238 related articles for article (PubMed ID: 18579347)
1. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.
Domschke K; Dannlowski U; Ohrmann P; Lawford B; Bauer J; Kugel H; Heindel W; Young R; Morris P; Arolt V; Deckert J; Suslow T; Baune BT
Eur Neuropsychopharmacol; 2008 Oct; 18(10):751-9. PubMed ID: 18579347
[TBL] [Abstract][Full Text] [Related]
2. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.
Baune BT; Dannlowski U; Domschke K; Janssen DG; Jordan MA; Ohrmann P; Bauer J; Biros E; Arolt V; Kugel H; Baxter AG; Suslow T
Biol Psychiatry; 2010 Mar; 67(6):543-9. PubMed ID: 20044070
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression.
Domschke K; Dannlowski U; Hohoff C; Ohrmann P; Bauer J; Kugel H; Zwanzger P; Heindel W; Deckert J; Arolt V; Suslow T; Baune BT
Eur Neuropsychopharmacol; 2010 May; 20(5):301-9. PubMed ID: 19854625
[TBL] [Abstract][Full Text] [Related]
4. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic genes modulate amygdala activity in major depression.
Dannlowski U; Ohrmann P; Bauer J; Kugel H; Baune BT; Hohoff C; Kersting A; Arolt V; Heindel W; Deckert J; Suslow T
Genes Brain Behav; 2007 Oct; 6(7):672-6. PubMed ID: 17284168
[TBL] [Abstract][Full Text] [Related]
6. Habitual emotion regulation strategies and depressive symptoms in healthy subjects predict fMRI brain activation patterns related to major depression.
Abler B; Hofer C; Walter H; Erk S; Hoffmann H; Traue HC; Kessler H
Psychiatry Res; 2010 Aug; 183(2):105-13. PubMed ID: 20630713
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression.
Domschke K; Hohoff C; Mortensen LS; Roehrs T; Deckert J; Arolt V; Baune BT
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):224-8. PubMed ID: 17884271
[TBL] [Abstract][Full Text] [Related]
8. Event-related functional magnetic resonance imaging measures of neural activity to positive social stimuli in pre- and post-treatment depression.
Schaefer HS; Putnam KM; Benca RM; Davidson RJ
Biol Psychiatry; 2006 Nov; 60(9):974-86. PubMed ID: 16780808
[TBL] [Abstract][Full Text] [Related]
9. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
[TBL] [Abstract][Full Text] [Related]
10. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
11. Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting-state fMRI study.
Yao Z; Wang L; Lu Q; Liu H; Teng G
J Affect Disord; 2009 Jun; 115(3):430-8. PubMed ID: 19007997
[TBL] [Abstract][Full Text] [Related]
12. Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies.
Delaveau P; Jabourian M; Lemogne C; Guionnet S; Bergouignan L; Fossati P
J Affect Disord; 2011 Apr; 130(1-2):66-74. PubMed ID: 21030092
[TBL] [Abstract][Full Text] [Related]
13. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1).
Barrero FJ; Ampuero I; Morales B; Vives F; de Dios Luna Del Castillo J; Hoenicka J; García Yébenes J
Pharmacogenomics J; 2005; 5(2):135-41. PubMed ID: 15668727
[TBL] [Abstract][Full Text] [Related]
14. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
15. Cortico-limbic response to personally challenging emotional stimuli after complete recovery from depression.
Hooley JM; Gruber SA; Parker HA; Guillaumot J; Rogowska J; Yurgelun-Todd DA
Psychiatry Res; 2009 Feb; 171(2):106-19. PubMed ID: 19176279
[TBL] [Abstract][Full Text] [Related]
16. A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.
Witkin JM; Tzavara ET; Davis RJ; Li X; Nomikos GG
Trends Pharmacol Sci; 2005 Dec; 26(12):609-17. PubMed ID: 16260047
[TBL] [Abstract][Full Text] [Related]
17. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
[TBL] [Abstract][Full Text] [Related]
18. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression.
Frodl T; Koutsouleris N; Bottlender R; Born C; Jäger M; Mörgenthaler M; Scheuerecker J; Zill P; Baghai T; Schüle C; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
Mol Psychiatry; 2008 Dec; 13(12):1093-101. PubMed ID: 19008895
[TBL] [Abstract][Full Text] [Related]
19. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
20. No association of CNR1 gene variations with susceptibility to schizophrenia.
Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
